SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016765
Filing Date
2017-08-09
Accepted
2017-08-09 08:11:26
Documents
54
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cemp-10q_20170630.htm 10-Q 1138541
2 EX-31.1 cemp-ex311_8.htm EX-31.1 17121
3 EX-31.2 cemp-ex312_7.htm EX-31.2 17050
4 EX-32.1 cemp-ex321_9.htm EX-32.1 6378
5 EX-32.2 cemp-ex322_6.htm EX-32.2 6273
  Complete submission text file 0001564590-17-016765.txt   4381166

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cemp-20170630.xml EX-101.INS 797563
7 XBRL TAXONOMY EXTENSION SCHEMA cemp-20170630.xsd EX-101.SCH 42154
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cemp-20170630_cal.xml EX-101.CAL 28441
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cemp-20170630_def.xml EX-101.DEF 127560
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemp-20170630_lab.xml EX-101.LAB 336542
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemp-20170630_pre.xml EX-101.PRE 236242
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
CEMPRA, INC. (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 171016504
SIC: 2834 Pharmaceutical Preparations